Latest Financial News


Trending: stimulus, earnings, nikkei, Google, debt, dollar, News Corp, oil, nasdaq

Industries > MedTech

» Abbott News (view all)

Abbott Laboratories: Undervalued Potential Seeking Alpha 1 day ago

Abbott Laboratories' Management Presents at UBS Global Healthcare Conference (Transcript) Seeking Alpha 2 days ago

Analyst Moves: ABT, ACN, EFX, JCP Forbes 4 days ago

UPDATE: Goldman Sachs Upgrades Abbott Laboratories; Growth Is Poised To Accelerate Benzinga 4 days ago

Benzinga's Top Upgrades Benzinga 4 days ago

» Amgen News (view all)

Amgen: Financial Analysis And Valuation Seeking Alpha 17 hours ago

UPDATE: Goldman Sachs Reiterates Buy Rating, $130 PT on Amgen Ahead of AMG 386 Phase 3 Data Benzinga 2 days ago

Amgen, Inc. Management Presents at UBS Global Healthcare Conference (Transcript) Seeking Alpha 3 days ago

Will Amgen's Novel Drug Revolutionize Cancer Treatment? The Motley Fool 4 days ago

Here's Why Amgen Shares Are Worth $117 To $126 Today Seeking Alpha 7 days ago

» Astrazeneca News (view all)

3 Neil Woodford High-Yield Shares The Motley Fool 3 days ago

Results from Phase III Studies of Naloxegol for Treatment of Opioid-Induced Constipation Presented at Digestive Disease Week 2013 Benzinga 3 days ago

AstraZeneca closes in on site for new home in Cambridge Reuters 4 days ago

» Baxter News (view all)

Acadia's CEO Presents at Bank of America Merrill Lynch Healthcare Conference (Transcript) Seeking Alpha 1 week ago

Baxter International Inc. - Shareholder/Analyst Call Seeking Alpha 2 weeks ago

Baxter International's CEO Hosts 2013 Annual Meeting of Shareholders (Transcript) Seeking Alpha 2 weeks ago

UPDATE 2-Baxter's Alzheimer's disease drug fails in late-stage trial Reuters 2 weeks ago

» Bayer News (view all)

Bayer says lung drug shows promise in prolonged trial Reuters 4 days ago

U.S. pesticide makers seek answers as bee losses sting agriculture Reuters 4 days ago

» Biogen News (view all)

Another Multiple Sclerosis Winner for Biogen The Motley Fool 3 days ago

Biogen submits new MS drug for FDA approval CNBC 3 days ago

Biogen Idec Submits BLA to FDA for Approval of PLEGRIDY for Multiple Sclerosis Benzinga 4 days ago

Biogen Idec Submits Application to FDA for Approval of PLEGRIDY™ (Peginterferon Beta-1a) in Multiple Sclerosis The Motley Fool 4 days ago

Leerink Swann Highlights Big Gains in Prescriptions for Biogen's MS Treatment Benzinga 4 days ago

» Boston Scientific News (view all)

OrbusNeich Seizes 190 Boston Scientific Stents in Germany in Patent Infringement Suit Benzinga 4 days ago

1 Pioneering Device to Jump-Start the Cardiovascular Industry The Motley Fool 4 days ago

Vascular Solutions Issues Patent Infringement Complaint Against Boston Scientific Benzinga 1 week ago

Vascular Solutions Files Patent Infringement Complaint Against Boston Scientific Benzinga 1 week ago

UPDATE: JP Morgan Raises PT on Boston Scientific on Recent FX Movements and 1Q Result Benzinga 1 week ago

» Bristol Myers News (view all)

Wall Street Loves this New Immunotherapy Cancer Drug The Motley Fool 2 days ago

Bristol-Myers Squibb lifted to buy at Citi MarketWatch 3 days ago

Bristol Myers Squibb And The New Wave Of Cancer Drugs Seeking Alpha 4 days ago

Bristol-Myers, Merck And Roche: R&D Finds Golden Pill, So Buy Seeking Alpha 1 week ago

Melanoma Treatment Harnesses Immune System to Combat Cancer Cells NY Times 1 week ago

» Cardinal Health News (view all)

Cardinal Health Named Top Dividend Stock With Insider Buying and 2.54% Yield Forbes 4 days ago

Cardinal Health Management Discusses Q3 2013 Results - Earnings Call Transcript Seeking Alpha 3 weeks ago

Cardinal Health profit up as sales drop MarketWatch 3 weeks ago

Cardinal Health Earnings Preview: Can This Streak Continue? Wall St Cheat Sheet 3 weeks ago

Forbes Earnings Preview: Cardinal Health Forbes 3 weeks ago

» Celgene News (view all)

Celgene Announces U.S. FDA Grants Priority Review for ABRAXANE® sNDA in Advanced Pancreatic Cancer The Motley Fool 1 day ago

Celgene Announces FDA Grants Priority Review for ABRAXANE sNDA in Advanced Pancreatic Cancer Benzinga 1 day ago

Celgene's Management Presents at 2013 UBS Global Healthcare Conference (Transcript) Seeking Alpha 2 days ago

Celgene: Apremilast For Psoriatic Arthritis Offers Upside Seeking Alpha 1 week ago

Short Interest in Vertex Rises, in Celgene Falls Benzinga 2 weeks ago

» Eli Lilly News (view all)

Corgenix Announces Collaboration with Lilly Benzinga 3 days ago

Lilly CEO recovering after repair to aorta Reuters 1 week ago

Eli Lilly & Co. About To Put More Money In Your Pocket Forbes 2 weeks ago

UPDATE 1-Eli Lilly lymphoma drug fails in late-stage trial Reuters 2 weeks ago

» Gilead News (view all)

2013 FDA Drug Approval Calendar TheStreet 4 days ago

Gilead Sciences' Management Presents at the 2013 UBS Global Healthcare Conference (Transcript) Seeking Alpha 4 days ago

Gilead Offers Response Data from Phase 2 Study of Idelalisib Benzinga 1 week ago

ASCO '13 Preview: Gilead's Big Cancer Debut TheStreet 1 week ago

Experimental Gilead drug effective in early-stage leukemia trial Reuters 1 week ago

» Glaxosmithkline News (view all)

GSK flu shot may raise adult narcolepsy risk -Finnish scientists Reuters 2 days ago

U.S. to Fund Glaxo's Research on Antibiotics WSJ 2 days ago

Government Inks Deal With GlaxoSmithKline To Tackle Drug Resistance, Bioterrorism Huffington Post 2 days ago

» Intuitive Surgical News (view all)

Intuitive Surgical: Years Of Super Growth Ahead Seeking Alpha 2 days ago

5 Healthcare Stocks With The Highest EPS Benzinga 2 weeks ago

This High-Growth Health Care Stock's Troubles Continue The Motley Fool 2 weeks ago

Do Micro-Cracks Equal Major Problems? The Motley Fool 2 weeks ago

Intuitive Surgical Flags Da Vinci ‘Issue’ CNBC 2 weeks ago

» Life Technologies News (view all)

Roche, Sigma teamed up for failed Life Technologies bid -sources Reuters 3 days ago

The Deal: Thermo Fisher's Purchase of Life Technologies Runs Through China TheStreet 2 weeks ago

» McKesson News (view all)

McKesson Declares Common Stock Dividend The Motley Fool 2 days ago

CORRECTED-BRIEF-McKesson Q4 results Reuters 2 weeks ago

CORRECTED-McKesson forecasts strong profit growth in fiscal 2014 Reuters 2 weeks ago

» Medtronic News (view all)

Dividend Growth Gem Medtronic Is A Cash Cow Seeking Alpha 15 hours ago

Medtronic's Defibrillator Sales Show A Pulse With Encouraging Results Seeking Alpha 2 days ago

UPDATE: Oppenheimer Raises PT on Medtronic Following Solid FQ4 Sales Benzinga 2 days ago

UPDATE: Jefferies Raises PT on Medtronic Following Solid F4Q Beat Benzinga 2 days ago

Medtronic’s 4th-Quarter Revenue Rises 4% NY Times 3 days ago

» Mylan News (view all)

Mylan's Management Presents at UBS Global Healthcare Conference (Transcript) Seeking Alpha 2 days ago

Mylan, Inc. Presents at UBS Global Healthcare Conference, May-22-2013 09:30 AM Seeking Alpha 2 days ago

Bernstein Believes Mylan Could Offer $22/Share for Warner Chilcott, Calls Deal with Actavis More Likely Benzinga 3 days ago

Drug Firms Stalk Actavis WSJ 1 week ago

Mylan: Solid Results Despite Revenue Miss Seeking Alpha 1 week ago

» Novartis News (view all)

Ariad's Cancer Drug Iclusig Extends The Gleevec Magic Seeking Alpha 2 days ago

New data reinforces strength of Novartis once-daily COPD portfolio in improving lung function, shortness of breath and reducing rate of exacerbations Benzinga 3 days ago

Ireland Welcomes Watson Pharmaceuticals, an American Success TheStreet 4 days ago

Atlas Venture Closes Fund IX with $265 Million peHUB 1 week ago

DEALTALK-Novartis' Vasella exit opens door to Roche stake sale Reuters 1 week ago

» Pfizer News (view all)

Pfizer Has Potential To Grow Despite Decreasing Sales Seeking Alpha 17 hours ago

Pfizer: split-off FT 1 day ago

Pfizer Takes Its Shot At A Vaccine For Evasive MRSA Superbug Huffington Post 1 day ago

MannKind's Afrezza And The Oramed Threat Seeking Alpha 1 day ago

RPT-FEATURE-Pfizer takes its shot at a vaccine for evasive superbug Reuters 2 days ago

» Roche News (view all)

Japan's Decline Is Elementary Seeking Alpha 1 day ago

Roche presents automated lab solution at conference Reuters 3 days ago

Analog Devices Management Discusses Q2 2013 Results - Earnings Call Transcript Seeking Alpha 3 days ago

The Japanese Market Is Just Ridiculous Business Insider 3 days ago

Roche, Sigma teamed up for failed Life Technologies bid -sources Reuters 3 days ago

» Sanofi News (view all)

UPDATE 1-Regeneron, Sanofi asthma drug seen as potential game changer Reuters 3 days ago

Regeneron, Sanofi asthma drug seen as potential game changer Reuters 3 days ago

» Stryker News (view all)

Stryker's Stock Looks Pricey TheStreet 1 week ago

Earnings Pain Intensifies in the Medical-Device Industry The Motley Fool 4 weeks ago

Maybe More Than Meets The Eye To Stryker's Numbers Seeking Alpha 4 weeks ago

Stryker Management Discusses Q1 2013 Results - Earnings Call Transcript Seeking Alpha 4 weeks ago

Stryker Earnings: Here’s Why Investors are Happy Now Wall St Cheat Sheet 4 weeks ago

» Teva News (view all)

Ireland Welcomes Watson Pharmaceuticals, an American Success TheStreet 4 days ago

A Broad Look At Teva's Pipeline Seeking Alpha 5 days ago

Alexza Pharmaceuticals Has A Partner In Big Pharma, Now What? Seeking Alpha 1 week ago

Alexza Pharmaceuticals: A Teva Partnership Of Immense Meaning Seeking Alpha 1 week ago

Teva: An Ideal Long-Term Pharma Stock Seeking Alpha 2 weeks ago